Ibuprofen/famotidine, commercially available vs phase III fixed combination formulation, in healthy subjects

Trial Profile

Ibuprofen/famotidine, commercially available vs phase III fixed combination formulation, in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Feb 2011

At a glance

  • Drugs Ibuprofen; Ibuprofen/famotidine
  • Indications Arthritis; Musculoskeletal pain; NSAID-induced gastrointestinal damage
  • Focus Pharmacokinetics
  • Sponsors Horizon Pharma USA
  • Most Recent Events

    • 07 Feb 2011 Not the official study title.
    • 27 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top